Interestingly, our recent study showed that IDH2 was overexpressed in colorectal cancer cells and a knockdown of IDH2 in HCT-116 and HT-29 cells led to a decrease in α-KG [40], suggesting that IDH2 might mainly catalyze the oxidative TCA metabolism in colon cancer cells. This evidence concerns the gene IDH2 and colorectal cancer.